AAP Circumcision Task Force 1999 - Revision history

WikiModEn2: Add SEEALSO section.

2024-04-23T15:56:08Z

Add SEEALSO section.

← Older revision		Revision as of 15:56, 23 April 2024
Line 39:		Line 39:

	{{ABBR}}		{{ABBR}}
			{{SEEALSO}}
			* [[United States of America]]
	{{REF}}		{{REF}}

WikiModEn2: Add text; Remove Construction Zone template.

2022-10-24T16:46:35Z

Add text; Remove Construction Zone template.

← Older revision		Revision as of 16:46, 24 October 2022
Line 1:		Line 1:
	{{~~Construction Site~~}}		The '''{{FULLPAGENAME}}''' was formed to replace the deficient 1989 Circumcision Policy Statement that was produced under the chairmanship of [[Edgar J. Schoen]], which rejected the use of analgesia for the [[Pain\| pain of circumcision]].

			The 1999 Circumcision Policy Statement has issues of its own however. This statement discussed "potential benefits". The word ''potential'' is usually defined as existing in possibility but not in actuality, so the claimed ''potential benefits'' are actually unproven imaginary non-existent benefits.
	== Circumcision Policy Statement 1999 ==		== Circumcision Policy Statement 1999 ==

	{{Citation		{{Citation
	\|Title=Summary of Policy Statement 1999		\|Title=Summary of Policy Statement 1999
	\|Text=Existing scientific evidence demonstrates potential medical benefits of newborn male circumcision; however, these data are not sufficient to recommend routine neonatal circumcision. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural pain associated with circumcision; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If [[circumcision]] is performed in the newborn period, it should only be done on infants who are stable and healthy.		\|Text=Existing scientific evidence demonstrates potential medical benefits of newborn male [[circumcision]]; however, these data are not sufficient to recommend [[Routine Infant Circumcision\| routine neonatal circumcision]]. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural [[pain]] associated with [[circumcision]]; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If [[circumcision]] is performed in the newborn period, it should only be done on infants who are stable and healthy.
	\|Author=AAP Task Force on Circumcision		\|Author=AAP Task Force on Circumcision
	\|Source=		\|Source=
Line 33:		Line 35:
	* Jack T. Swanson, {{MD}}		* Jack T. Swanson, {{MD}}
	* Donald Coustan, {{MD}}		* Donald Coustan, {{MD}}
			==Termination==
			The 1999 Circumcision Policy Statement was replaced by the publication in Pediatrics of a far more deeply flawed and disastrous Circumcision Policy Statement on 1 September 2012 that was produced by the [[AAP Circumcision Task Force 2012]].

	{{ABBR}}		{{ABBR}}
Line 41:		Line 45:
	[[Category:From CircLeaks]]		[[Category:From CircLeaks]]
	[[Category:From IntactWiki]]		[[Category:From IntactWiki]]

			[[Category:USA]]

	[[de:{{FULLPAGENAME}}]]		[[de:{{FULLPAGENAME}}]]

WikiModEn2: /* Circumcision Policy Statement 1999 */ Wikify.

2022-10-24T16:03:02Z

Circumcision Policy Statement 1999: Wikify.

← Older revision		Revision as of 16:03, 24 October 2022
Line 4:		Line 4:
	{{Citation		{{Citation
	\|Title=Summary of Policy Statement 1999		\|Title=Summary of Policy Statement 1999
	\|Text=Existing scientific evidence demonstrates potential medical benefits of newborn male circumcision; however, these data are not sufficient to recommend routine neonatal circumcision. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural pain associated with circumcision; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If circumcision is performed in the newborn period, it should only be done on infants who are stable and healthy.		\|Text=Existing scientific evidence demonstrates potential medical benefits of newborn male circumcision; however, these data are not sufficient to recommend routine neonatal circumcision. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural pain associated with circumcision; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If [[circumcision]] is performed in the newborn period, it should only be done on infants who are stable and healthy.
	\|Author=AAP Task Force on Circumcision		\|Author=AAP Task Force on Circumcision
	\|Source=		\|Source=

WikiModEn2: WikiModEn2 moved page AAP Circumcision Task Force 2019 to AAP Circumcision Task Force 1999: Correct date.

2022-01-12T17:56:26Z

WikiModEn2 moved page AAP Circumcision Task Force 2019 to AAP Circumcision Task Force 1999: Correct date.

← Older revision	Revision as of 17:56, 12 January 2022
(No difference)

WikiAdmin: extracted from AAP Circumcision Task Force 2012

2022-01-10T18:04:40Z

extracted from AAP Circumcision Task Force 2012

New page

{{Construction Site}}
== Circumcision Policy Statement 1999 ==

{{Citation
|Title=Summary of Policy Statement 1999
|Text=Existing scientific evidence demonstrates potential medical benefits of newborn male circumcision; however, these data are not sufficient to recommend routine neonatal circumcision. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural pain associated with circumcision; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If circumcision is performed in the newborn period, it should only be done on infants who are stable and healthy.
|Author=AAP Task Force on Circumcision
|Source=
|ref=<ref name="AAP 1999">{{REFjournal
|url=http://pediatrics.aappublications.org/content/103/3/686.full.pdf+html
|title=Circumcision Policy Statement
|last=AAP Task Force on Circumcision
|publisher=[[AAP]]
|journal=Pediatrics
|volume=103
|issue=3
|pages=686–93
|DOI=10.1542/peds.103.3.686
|date=1999-03-01
|accessdate=2022-01-10
}}</ref>
}}

== Task Force on Circumcision 1999 ==

Members of the Task Force on circumcision 1998-1999<ref name="AAP 1999"/>:

* Carole M. Lannon, {{MD}}, {{MPH}}, Chairperson
* Ann Geryl Doll Bailey, {{MD}}
* Alan R. Fleischman, {{MD}}
* [[George W. Kaplan]], {{MD}}
* Craig T. Shoemaker, {{MD}}
* Jack T. Swanson, {{MD}}
* Donald Coustan, {{MD}}

{{ABBR}}
{{REF}}

[[Category:American Academy of Pediatrics]]

[[Category:From CircLeaks]]
[[Category:From IntactWiki]]

[[de:{{FULLPAGENAME}}]]